All about Osteoarthritis (in 20 minutes - PowerPoint PPT Presentation

1 / 72
About This Presentation
Title:

All about Osteoarthritis (in 20 minutes

Description:

Title: IVIG Subject: IVIg Author: Yehuda & Amir Shoenfeld Last modified by: nivz Created Date: 9/30/1996 6:28:10 PM Document presentation format: 35mm Slides – PowerPoint PPT presentation

Number of Views:113
Avg rating:3.0/5.0
Slides: 73
Provided by: yeh35
Category:

less

Transcript and Presenter's Notes

Title: All about Osteoarthritis (in 20 minutes


1
  • All about Osteoarthritis (in 20 minutes)

Howard Amital, MD, MHA Daniela Amital, MD,
MHA Department of Medicine D Meir Medical
Center, Kfar-Saba
Wear and tear of the joints
2
Definition
  • Also known as degenerative joint disease or
    wear and tear arthritis.
  • Progressive loss of cartilage with remodeling of
    subchondral bone and progressive deformity of the
    joint (s).
  • Cartilage destruction may be a result of a
    variety of etiologies

3
  • Prevalence and epidemiology
  • Over 20 million affected in U.S.
  • About 60-90 of people over age 65
  • Under 45 yrs it is equally common in men and
    women
  • Over 55 yrs its more common in women
  • Nodal OA involving DIP and PIP joints is more
    common in women and their first degree female
    relatives

4
Age-Related Prevalence of OA Changes on X-Ray
Men
Women
DIP
DIP
Knee
Prevalence of OA ()
Prevalence of OA ()
Knee
Hip
Hip
Age (years)
Age (years)
5
  • Premature OA associated with gene mutations that
    encode collagen types 2, 9, 10
  • OA of knee is more common in African American
    women
  • Commonest cause of long-term disability
  • Large economic impact as a result of medical
    costs
  • OA cost the U.S. economy nearly 125 billion per
    year in direct expenses and lost wages and
    production.

6
  • Risk factors
  • Metabolic (hemachromatosis)
  • Inflammatory (RA, infection)
  • age
  • gender

7
  • Risk factors
  • genetic factors
  • trauma
  • weight

8
Classification
  • Primary
  • Idopathic
  • Localized or generalized
  • Local knee, hip, spine, hands
  • Generalized large joints and spine
  • Small peripheral joints and spine
  • Mixed and spine
  • Secondary
  • Post-traumataic
  • Congenital or developmental
  • Localized or generalized
  • Calcium deposition disease
  • Other
  • Inflammatory
  • Avascular necrosis

9
The process at a cellular level
  • Cartilage matrix has increased water content and
    decreased proteoglycan
  • This is different from the changes that occur
    with aging ? cartilage dries up.
  • Increased activity of proteinases compared to
    inhibitors of proteinases.
  • Breakdown products of cartilage cause
    inflammatory reaction of synovium
  • Cytokines cause matrix degeneration. Where do
    they come from?
  • ? chondrocytes
  • Cycle of destruction starts
  • Compensatory bone overgrowth occurs - subchondral
    bone increases in density

10
Overview of the process
  • Articular cartilage gets disrupted
  • Damage progresses deeper to subchondral bone

11
  • Fragments of cartilage released into joint
  • Matrix degenerates
  • Eventually there is complete loss of cartilage
  • Bone is exposed

12
(No Transcript)
13
(No Transcript)
14
What to look for in an x-ray
  • Radiographic changes visible relatively late in
    the disease
  • Subchondral sclerosis
  • Joint space narrowing esp where there is stress
  • Subchondral cysts
  • Osteophytes
  • Bone mineralization should be normal

15
  • Left View of normal elbow cartilage through an
    arthroscope - white, glistening, smooth
  • Right severe elbow osteoarthritis - cartilage is
    lost and the bone underneath is exposed

16
  • left Normal x-ray
  • Right worn away cartilage reflected by decreased
    joint space

17
  • Joint space narrowing where there is more stress
  • Subchondral bone has thickened
  • bony overgrowth

18
(No Transcript)
19
  • significant joint space narrowing as well as
    proliferative bone formation around the femoral
    neck (arrows)

20
  • painful bone on bone contact at the CMC joint and
    the large bone spurs -- osteophytes.

21
  • Are crystals found in osteoarthritic joints?
  • Yes
  • Calcium pyrophosphate dihydrate and apatite.
  • Are of unknown significance and asymptomatic

22
Clinical features and diagnosis
  • Pain
  • Sources
  • Joint effusion and stretching of the joint
    capsule
  • Torn menisci
  • Inflammation of periarticular bursae
  • Periarticular muscle spasm
  • Psychological factors
  • Deep, aching localized to the joint
  • Slow in onset
  • Worsened with activity in initial stages
  • Occurs at rest with advanced disease

23
Involved joints
  • DIP, PIP
  • 1st carpometacarpal
  • cervical/lumbar facet joints
  • 1st metatarsophalangeal
  • Hips
  • Knees
  • Uncommon
  • Wrist, elbows, shoulders, ankles

24
(No Transcript)
25
  • 1st metatarso-phalangeal most commonly affected
    in OA of the foot.

26
Typical findings
  • Heberdens nodes
  • Bouchards nodes

27
  • Rt varus deformity of the knee

28
Treatment
  • Non-pharmacokinetic
  • No proven medication-based disease modifying
    intervention exists.
  • Analgesics (acetominophen)
  • NSAIDS
  • Help pain symptoms but controversial for long
    term use in non-inflammatory OA because of risks
    vs benefits
  • Narcotics
  • Intra-articular steroids
  • Chondroprotective agents
  • Anti-depressants
  • Physical activity

29
Intra-articular corticosteroids
  • May be used if NSAIDS are contraindicated,
    persistent pain despite use of other medications.
  • (not gt 4 injections per year per joint)
  • 2004 meta-analysis of controlled trials (w/
    placebo) showed short term improvement in knee
    pain, but efficacy in other joints is uncertain.
  • saline vs steroid injection?
  • A study comparing the two in knee OA showed no
    effect on joint space narrowing or significant
    difference in pain at the end of the study, but
    over a 2 yr period saline injections has less
    pain relief.

30
Intra-articular hyaluronans
  • Evidence shows they have a small advantage in
    terms of pain control, compared to
    intra-articular placebos or NSAIDS.
  • No evidence for improvement in function
  • Two studies comparing intra-articular steroids to
    hyaluronans have come to opposite
    conclusions-more trials are needed.

31
Surgical arthroscopy
  • arthroscopy is not recommended for nonspecific
    "cleaning of the knee.
  • Used to fix specific structural damage on imaging
    (repairing meniscal tears, removing fragments of
    torn menisci that are producing symptoms).

32
  • Joint replacement
  • If all other rx ineffective, and pain is severe
  • Loss of joint function
  • Joints last 8-15 years without complications

33
  • Fibromyalgia
  • Are new horizons seen ?
  • OR Fibromyalgia for the psychiatrist

Howard Amital, MD, MHA Daniela Amital, MD,
MHA Department of Medicine D Meir Medical
Center, Kfar-Saba
34
  • "The Three Graces" by Peter Paul Rubens
    (1577-1640), Prado, Madrid, Spain.

35
  • Fibromyalgia - criteria
  • Widespread musculoskeletal pain
  • Excess tenderness in at least 11 of 18
    predefined anatomic

36
Frida Kahlo (1907-1954)
37
Frida used to describe her own paintings as "the
most frank expression of myself"
38
The Broken Column
39
(No Transcript)
40
Chronic Pain Defined by Mechanisms
  • Peripheral (nociceptive)
  • Primarily due to inflammation or damage in
    periphery
  • NSAID, opioid responsive
  • Behavioral factors minor
  • Examples
  • OA
  • Acute pain models (e.g. third molar,
    post-surgery)
  • RA
  • Cancer pain
  • Central (non-nociceptive)
  • Primarily due to a central disturbance in pain
    processing
  • Tricyclic responsive
  • Behavioral factors more prominent
  • Examples
  • Fibromyalgia
  • Irritable bowel syndrome
  • Tension and migraine headache
  • Interstitial cystitis / vulvodynia, non-cardiac
    chest pain / etc.
  • Mixed
  • Neuropathic

41
(No Transcript)
42
  • Fibromyalgia - some facts
  • 10 times more common in females Studies of
    humans and of animals have noted that females
    have a lower pain threshold and tolerance and a
    higher sensitivity to various noxious stimuli.
    Pillemer et al. Arthritis Rheum.
    1997401928-1939
  • Prevalence in the community increases with age
    from
    2 at age 20 to 8 at age 70
  • Most patients present between the ages of 30 and
    55
  • Approximately 50 of cases appear after a
    specific event, most often (physical or
    emotional trauma)
  • Wolfe F et al. Arthritis Rheum 1995, 3819-28.

43
(No Transcript)
44
(No Transcript)
45
(No Transcript)
46
(No Transcript)
47
(No Transcript)
48
(No Transcript)
49
(No Transcript)
50
(No Transcript)
51
  • The tender point count functions as a
    sedimentation rate' for distress

52
WHAT IS THE ASSOCIATION BETWEEN FM AND
PSYCHIATRIC ILLNESS? - Depression
  • A lifetime history of depression has been
    reported in 50 to 70
  • Current major depression, however, was found in
    only 18 to 36

Goldenberg DL et al, Arthritis Rheum.
1996391852-1859 Goldenberg DL et al, Arch
Intern Med, 1999159777-785
53
WHAT IS THE ASSOCIATION BETWEEN FM AND
PSYCHIATRIC ILLNESS? - Depression
  • Similar symptoms fatigue, sleep disturbances,
    and cognitive disturbances.
  • Similar comorbid conditions migraines, muscular
    headaches, CFS, IBS, and premenstrual syndrome.
  • Often improve with antidepressant medications

Triadafilopoulos G et al, Dig Dis Sci.
19913659-64.
54
WHAT IS THE ASSOCIATION BETWEEN FM AND
PSYCHIATRIC ILLNESS? - other psychiatric
disturbances
  • Dysthymia - 10 Current prevalence (CP)
  • Panic disorder - lifetime prevalence (LP) -16,
    CP- 7
  • Phobia LP - 16, CP -12.

Epstein SA et al. Psychosomatics 19994057-63.
55
(No Transcript)
56
The overlapping ill defined disorders
FIBROMYALGIA 2 - 4 of population defined by
widespread pain and tenderness
MULTIPLE CHEMICAL SENSITIVITY - symptoms in
multiple organ systems in response to multiple
substances
CHRONIC FATIGUE SYNDROME 1 of population
fatigue and 4/8 minor criteria
SOMATOFORM DISORDERS 4 of population multiple
unexplained symptoms - no organic findings
EXPOSURE SYNDROMES e.g. Gulf War Illnesses,
silicone breast implants, sick building syndrome
57
(No Transcript)
58
Rate of fibromyalgia
plt0.001 ?240 (d.f 2)
59
Distribution of severity of FM
No. of patients
plt0.0001 ?260.5 (d.f 8)
60
Results average tender point count
plt0.001, Anova
  • Controls (n49) 0.18 0.4
  • PTSD (n55) 8.9 5.4
  • Depression - (n20) 2.85 3

Clinical Global Impression (CGI) PTSD
5.67 DEPRESSION 5.65
p0.62, Anova
61
(No Transcript)
62
(No Transcript)
63
(No Transcript)
64
(No Transcript)
65
(No Transcript)
66
(No Transcript)
67
(No Transcript)
68
(No Transcript)
69
(No Transcript)
70
A Six-month, Double-blind, Placebo-controlled,
Durability of Effect Study of Pregabalin for Pain
Associated With Fibromyalgia Crofford et al ACR
2006
  • By the end of the study nearly twice as many
    placebo patients (61) had lost therapeutic
    response compared with pregabalin-treated
    patients (32).
  • The most common AEs considered treatment related
    during OL were dizziness (36) and somnolence
    (22).

71
(No Transcript)
72
Thank you for your attention
Write a Comment
User Comments (0)
About PowerShow.com